This
Agreement is by and between The Topps Company, Inc. with offices at
One Whitehall Street, New York, NY 10004-2109 (hereinafter
“Licensee”), and NATIONAL FOOTBALL LEAGUE PLAYERS
ASSOCIATION, a corporation with offices at 2021 L Street, N.W.,
Suite 600, Washington, D.C., 20036 (hereinafter
“NFLPA” or “Licensor”). This Agreement
shall be effective as of March 1, 2004.
(A) NFLPA
represents that the NFLPA has been duly appointed and is acting on
behalf of the active and retired football players of the National
Football League (hereinafter “NFL”) who have entered
into a Group Licensing Assignment, either in the form attached
hereto as Attachment “A” or through the assignment
contained in Paragraph 4(b) of the NFL Player Contract, and that in
such capacity NFLPA has the right to grant rights and licenses
described herein. Licensee acknowledges that NFLPA also on occasion
secures authorization for inclusion in NFLPA licensing programs
from players, including but not limited to retired players, who
have not entered into such Group Licensing Assignment, but who,
nevertheless, authorize NFLPA to represent such players for
designated NFLPA licensed programs.
(B) NFLPA
makes no representation that it has the authority to grant, nor
does it grant herein, the right to utilize any symbols, insignias,
logos, or other identifying names or marks of the NFL and/or any of
its member clubs. Accordingly, it is understood by the parties
hereto that if likenesses of players are to be used by Licensee in
conjunction with any symbols, insignia, or logos of the NFL or any
of its member clubs, in the exercise of the License granted
hereunder, it will be the responsibility of the Licensee to obtain
such permission as may be necessary for the use of such material
from the NFL or the club(s) in question. Licensor retains all
rights not expressly and exclusively granted to Licensee
hereunder.
(A) Upon the
terms and conditions hereinafter set forth, NFLPA hereby grants to
Licensee and Licensee hereby accepts [ INFORMATION SUBJECT TO
AN APPLICATION FOR CONFIDENTIAL TREATMENT. ]
(B) The
rights, licenses, and privileges granted by NFLPA hereunder shall
not constitute or be used by Licensee as a testimonial or an
endorsement of any product, service, or event by all or any of the
players, or by NFLPA or Players Inc.
(C) Licensee
acknowledges that the Grant of License of this Section 2 is
contingent upon Licensee’s compliance with and performance
under the terms and conditions of the Service Agreement between
Licensee and Players Inc, effective March 1, 2004 (hereinafter
“Service Agreement”). As provided in
Section 14(C), NFLPA may terminate this Agreement if Licensee
shall violate any of its material obligations under the terms of
the Service Agreement.
The
Grant of License set forth in Section 2 of this Agreement
applies [ INFORMATION SUBJECT TO AN APPLICATION FOR
CONFIDENTIAL TREATMENT. ]
4. TERRITORY
AND DISTRIBUTION.
Licensee shall
have the right to utilize the rights granted hereunder for
distribution of the licensed product(s) in the following territory:
Worldwide.
(A) The term
of this Agreement shall extend from [ INFORMATION SUBJECT TO
AN APPLICATION FOR CONFIDENTIAL TREATMENT ] (hereinafter
referred to as the Original License Period) unless terminated in
accordance with the provisions hereof. Licensee may renew this
Agreement for a Second License Period from [ INFORMATION
SUBJECT TO AN APPLICATION FOR CONFIDENTIAL TREATMENT ] ,
provided Licensee has materially fulfilled its obligations
hereunder in the Original License Period. Notice of desire to renew
shall be given by Licensee no later than [ INFORMATION
SUBJECT TO AN APPLICATION FOR CONFIDENTIAL TREATMENT ] in
the Original License Period. Licensee may renew this Agreement also
for a Third License Period from [ INFORMATION SUBJECT TO AN
APPLICATION FOR CONFIDENTIAL TREATMENT ] , provided
Licensee has faithfully fulfilled its obligations hereunder in the
Second License Period. Notice of desire to renew shall be given by
Licensee no later than [ INFORMATION SUBJECT TO AN
APPLICATION FOR CONFIDENTIAL TREATMENT ] of the Second
License Period.
(B) Licensee
acknowledges and agrees that Licensee has and shall have no right
to extend or renew this Agreement beyond the term and renewal
options, if any, stated herein. No conduct by either Licensor or
Licensee (including without limitation, any approvals granted
pursuant to the Service Agreement) shall create, imply, or infer a
new license agreement or an extension of the stated term and
renewal options, if any, of this Agreement, unless same is
specifically set forth in a written agreement signed by both
Licensor and Licensee. Licensee’s agreement that this
Agreement is subject to the term and renewal options, if any,
stated herein, in all events whatsoever, is a material inducement
for Licensor to enter into this Agreement.
(A) Licensee
agrees to pay NFLPA a guaranteed royalty of $ [ INFORMATION
SUBJECT TO AN APPLICATION FOR CONFIDENTIAL TREATMENT ] for
its use of the rights licensed hereunder for the Original License
Period, a guaranteed royalty of $ [ INFORMATION SUBJECT TO AN
APPLICATION FOR CONFIDENTIAL TREATMENT ] for the Second
License Period, if applicable, and a guaranteed royalty of $ [
INFORMATION SUBJECT TO AN APPLICATION FOR CONFIDENTIAL
TREATMENT ] for the Third License Period, if applicable.
The guaranteed royalty shall be paid as follows:
-2-
|
|
(i)
|
|
For
the Original License Period, $ [ INFORMATION SUBJECT TO AN
APPLICATION FOR CONFIDENTIAL TREATMENT. ]
|
|
|
|
|
|
|
|
(ii)
|
|
For
the Second License Period, if applicable, $ [ INFORMATION
SUBJECT TO AN APPLICATION FOR CONFIDENTIAL TREATMENT.
]
|
|
|
|
|
|
|
|
(iii)
|
|
For
the Third License Period, if applicable, $ [ INFORMATION
SUBJECT TO AN APPLICATION FOR CONFIDENTIAL TREATMENT.
]
|
(B) Such
guaranteed royalty payments shall be made by Licensee as specified
hereinabove whether or not Licensee uses the rights licensed
hereunder, and no part of such guaranteed payments shall be
repayable to Licensee.
(C) Licensee
shall also pay to NFLPA an amount equal to [ INFORMATION
SUBJECT TO AN APPLICATION FOR CONFIDENTIAL TREATMENT ] %)
of the gross sales of the licensed product(s) covered by this
Agreement, less the guaranteed payments specified above for the
applicable License Period. Royalties shall be calculated on a
quarterly basis and shall be due as of the last day of each May,
August, November, and February of this Agreement and must be paid
no later than fifteen (15) days following such due dates.
Gross sales shall be calculated based on the actual price(s)
charged by Licensee to the retailer or consumer directly or to the
wholesaler in an arm’s length transaction. Licensee shall
transact no sale, the effect of which is to reduce the royalty paid
by Licensee to NFLPA; provided, however, that Licensee shall be
permitted to provide arm’s length discounts, allowances, and
returns that are normal and customary. Gross sales shall exclude
only [ INFORMATION SUBJECT TO AN APPLICATION FOR CONFIDENTIAL
TREATMENT ] in any annual period of March 1 to February 28
contained herein, and (b) such exclusion shall be available to
Licensee only if Licensee has theretofore fully complied in a
timely manner with its obligation hereunder to pay all royalties,
including guarantees.
7. PAYMENT,
INTEREST AND NOTICES.
All transactions
under this Agreement including, without limitation, all payment of
royalties and all notices, reports, statements, approvals, and
other communications, shall be with or made payable in the name of
NATIONAL FOOTBALL LEAGUE PLAYERS ASSOCIATION, 2021 L Street NW,
Suite 500, Washington, DC 20036, or its assignee, where
applicable. All correspondence, notices, approvals, and other
communications to Licensee shall be with The Topps Company, Inc.
with offices at One Whitehall Street, New York, NY 10004-2109. With
regard to all guaranteed royalty and actual royalty payments
only , such payments shall be made by wire transfer in
accordance with Attachment “B” hereto. The payment made
hereunder (or the cashing of any check made hereunder) shall not
preclude NFLPA or Players Inc from questioning the correctness
thereof at any time and, in the event any inconsistencies or
mistakes are discovered in correction therewith, they shall
immediately be rectified and the appropriate payment made by
Licensee. In addition to all other rights contained in this
Agreement, NFLPA shall be entitled to collect and Licensee shall
pay daily interest at the rate of [ INFORMATION SUBJECT TO AN
APPLICATION FOR CONFIDENTIAL
-3-
TREATMENT ] %)
monthly, or the maximum interest permitted by law if less, on all
payments not timely made to NFLPA by Licensee.
(A) Licensee
agrees that it will not during the term of this Agreement, or
thereafter, challenge the rights of Players Inc or NFLPA in and to
the trademarks or names owned by or licensed to Players Inc or
NFLPA or any of the rights licensed as specified in Section 2
of the License Agreement, or in any way challenge the validity of
the Service Agreement or this Agreement.
(B) Licensee
further agrees to assist NFLPA and Players Inc to the extent
necessary in the procurement of any protection or to protect any of
the rights conveyed hereunder, and NFLPA, if it so desires, may
commence or prosecute at its own expense any claims or suits in its
own name or in the name of Licensee or join Licensee as a party
thereto. Licensee shall notify Players Inc in writing of any
infringement by others of the rights covered by this Agreement that
may come to Licensee’s attention, and Players Inc shall have
the sole right to determine whether or not any action shall be
taken on account of any such infringement. Licensee shall not
institute any suit or take any action on account of any such
infringement without first obtaining the written consent of Players
Inc to do so and Players Inc shall reasonably consider any such
request.
(C) For its
own acts, Licensee hereby indemnifies NFLPA and undertakes to
defend NFLPA from and against any and all claims, suits, losses,
damages, and expenses (including reasonable attorneys’ fees
and expenses) arising out of the manufacture, marketing, sale,
distribution, or use of the licensed product(s) that are the
subject of this Agreement, or any material breach by Licensee of
any portion of this Agreement. Licensee agrees to
|